Improving the drug delivery to tumor tissue

Project opportunity

This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.

Cancer is a leading cause of death in both Australia and the world. The use of nanomedicines to efficiently deliver therapeutic agents to tumor tissue represents a promising treatment approach to improving the lives of people diagnosed with cancer. Although significant progress has been made in recent decades to develop various types of nanomedicines for cancer therapy, very few of these have been approved for clinical use. This is largely due to the very low delivery efficiency of current nanomedicines to tumor tissue, resulting in limited and unsatisfactory therapeutic outcomes. The PhD research program will target this key roadblock for the clinical translation of nanomedicines, with the aim to develop a new type of nanomedicines that can overcome the biological barriers responsible for non-specific uptake and increase targeting capability to cancer cells, greatly increasing the chances of the nanomedicine reaching the target tumor tissue. The student will be advised by Dr Changkui Fu at AIBN, working on this highly multi-disciplined project.

Scholarship value

As a scholarship recipient, you'll receive: 

  • living stipend of $32,192 per annum tax free (2023 rate), indexed annually
  • tuition fees covered
  • single Overseas Student Health Cover (OSHC)


Dr Changkui Fu

Australian Institute for Bioengineering and Nanotechnology


Preferred educational background

Your application will be assessed on a competitive basis.

We take into account your

  • previous academic record
  • publication record
  • honours and awards
  • employment history.

A working knowledge of pharmaceutical science, chemistry, biology, nanotechnology, or other related scientific disciplines would be of benefit to someone working on this project.

The applicant will demonstrate academic achievement in the field(s) of nanomedicine and the potential for scholastic success.

A background or knowledge of chemistry and biology is highly desirable.

Latest commencement date

If you are the successful candidate, you must commence by Research Quarter 1, 2024. You should apply at least 3 months prior to the research quarter commencement date.

If you are an international applicant, you may need to apply much earlier for visa requirements.

How to apply

You apply for this project as part of your PhD program application.

View application process